Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F K Zhang

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Hematologic responses to avatrombopag switch in TPO-RA refractory aplastic anemia]L P Jing, H H Fan, W R Yang, et al.
Zhonghua Nei Ke Za Zhi|September 28, 2023
[Clinical characteristics of aplastic anemia patients with abnormal autoantibodies and the impact of autoantibodies on immunosuppressive therapy response]W R Liang, R Kang, X Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[The efficacy and safety of intravenous sucrose iron therapy for recurrent iron deficiency anemia]J Q Liu, X W Yang, X Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016
[Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine A plus ATG/ALG versus cyclosporine A plus androgens: a retrospective single center study]L Song, G X Peng, Z J Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Delayed hematologic response to immunosuppressive therapy in severe aplastic anemia]Y Yang, W R Yang, Z J Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 2, 2016
[Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy]K Zhou, Y Li, J P Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Reassessing the six months prognosis of patients with severe or very severe aplastic anemia without hematological responses at three months after immunosuppressive therapy]X R Hu, X Zhao, L Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[The effect of on-demand glucocorticoid strategy on the occurrence and outcome of p-ALG-associated serum sickness in aplastic anemia]X W Yang, K Zhou, J P Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2020
[Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China]W R Yang, B Han, H Chang, et al.
Zhonghua Nei Ke Za Zhi|October 10, 2019
[Red blood cell lifespan detected by endogenous carbon monoxide breath test in patients with polycythemia vera]Q Y Gao, Y M Zhu, J Hu, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Hematologic responses to avatrombopag switch in TPO-RA refractory aplastic anemia]L P Jing, H H Fan, W R Yang, et al.
Zhonghua Nei Ke Za Zhi|September 28, 2023
[Clinical characteristics of aplastic anemia patients with abnormal autoantibodies and the impact of autoantibodies on immunosuppressive therapy response]W R Liang, R Kang, X Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[The efficacy and safety of intravenous sucrose iron therapy for recurrent iron deficiency anemia]J Q Liu, X W Yang, X Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016
[Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine A plus ATG/ALG versus cyclosporine A plus androgens: a retrospective single center study]L Song, G X Peng, Z J Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Delayed hematologic response to immunosuppressive therapy in severe aplastic anemia]Y Yang, W R Yang, Z J Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 2, 2016
[Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy]K Zhou, Y Li, J P Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Reassessing the six months prognosis of patients with severe or very severe aplastic anemia without hematological responses at three months after immunosuppressive therapy]X R Hu, X Zhao, L Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[The effect of on-demand glucocorticoid strategy on the occurrence and outcome of p-ALG-associated serum sickness in aplastic anemia]X W Yang, K Zhou, J P Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2020
[Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China]W R Yang, B Han, H Chang, et al.
Zhonghua Nei Ke Za Zhi|October 10, 2019
[Red blood cell lifespan detected by endogenous carbon monoxide breath test in patients with polycythemia vera]Q Y Gao, Y M Zhu, J Hu, et al.
Pageof 4